. Mechanism of cGMP contribution to the vasodilator response to NO in rat middle cerebral arteries. Am J Physiol Heart Circ Physiol 282: H1724-H1731, 2002. First published January 10, 2002 10.1152/ajpheart.00699.2001.-This study examined the mechanism by which cGMP contributes to the vasodilator response to nitric oxide (NO) in rat middle cerebral arteries (MCA). Administration of a NO donor, diethylaminodiazen-1-ium-1,2-dioate (DEA-NONOate), or 8-bromo-cGMP (8-BrcGMP) increased the diameter of serotonin-preconstricted MCA by 79 Ϯ 3%. The response to DEA-NONOate, but not 8-BrcGMP, was attenuated by iberiotoxin (10 Ϫ7 M) or a 80 mM high-K ϩ media, suggesting that activation of K ϩ channels contributes to the vasodilator response to NO but not 8-BrcGMP. The effects of NO and cGMP on the vasoconstrictor response to Ca 2ϩ were also studied in MCA that were permeabilized with ␣-toxin and ionomycin. (6, 7, 36) have indicated that nitric oxide (NO) plays an important role in the regulation of cerebral blood flow and mediates the cerebral vascular responses to a wide variety of stimuli, including acetylcholine (ACh), substance P, bradykinin, and ␣ 2 -adrenergic receptor agonists. Inhibitors of NO synthase constrict cerebral arteries in vitro and decrease cerebral blood flow in vivo (10, 14, 27) . There is also evidence (10, 11) that impairment in NO-induced vasodilation plays an important role in the pathogenesis of cerebral vasospasm. Despite the importance of NO in the control of cerebral vascular tone, its mechanism of action particularly in the middle cerebral artery (MCA) of the rat remains to be fully defined . In addition, cGMP has also been shown to desensitize the contractile mechanism to elevations of [Ca 2ϩ ] i in VSM (25). Many of these mechanisms have been examined in the basilar artery of rabbits (24), dogs (31), sheep (18), guinea pigs (35), and even rats (23). However, few of these studies have examined multiple mechanisms in the same vessel and none have been done in the MCA of the rat. This latter point is potentially significant, because we (1, 33) and other researchers (19, 20) have noted that the mechanisms underlying the vasodilator response to NO appear to differ in the basilar artery and MCA of the rat. The vasodilator response to NO is completely cGMP dependent in the basilar artery of the rat (1, 29) and guinea pig (22) and is not affected by K Ca channel blockers (27). However, ϳ50% of the response to NO in MCA of rats is cGMP independent and is secondary to blockade of the formation of 20-hydroxyeicosatetraenoic acid (20-HETE) and activation of K Ca channels (1, 33). Furthermore, in patch-
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concentration ([Ca 2ϩ ]i) in control, serotonin-stimulated, or ␣-toxin-and ionomycin-permeabilized vascular smooth muscle cells isolated from the MCA. These results indicate that the vasodilator response to NO in rat MCA is mediated by activation of Ca 2ϩ -activated K ϩ channels via a cGMP-independent pathway and that cGMP also contributes to the vasodilator response to NO by decreasing the contractile response to elevations in [Ca 2ϩ ]i. vascular smooth muscle; calcium sensitivity; cytochrome P-450
RECENT STUDIES (6, 7, 36) have indicated that nitric oxide (NO) plays an important role in the regulation of cerebral blood flow and mediates the cerebral vascular responses to a wide variety of stimuli, including acetylcholine (ACh), substance P, bradykinin, and ␣ 2 -adrenergic receptor agonists. Inhibitors of NO synthase constrict cerebral arteries in vitro and decrease cerebral blood flow in vivo (10, 14, 27) . There is also evidence (10, 11) that impairment in NO-induced vasodilation plays an important role in the pathogenesis of cerebral vasospasm. Despite the importance of NO in the control of cerebral vascular tone, its mechanism of action particularly in the middle cerebral artery (MCA) of the rat remains to be fully defined. The results of previous in vivo studies indicating that 1H- [1, 2, 4] oxadiazole [4,3-a] quinoxalin-1-one (ODQ), an inhibitor of guanylyl cyclase (GC), blocks 80% of the vasodilator response to ACh and NO in pial arteries of the mouse, rat, and rabbit (4, 9, 28) and in the basilar artery of the rat (1, 29) in vivo support a primary role for cGMP in mediating the response to NO. The potential mechanisms by which cGMP contributes to the vasodilator response to NO in vascular smooth muscle (VSM) cells have been reviewed by Lincoln et al. (16 (26) . In addition, cGMP has also been shown to desensitize the contractile mechanism to elevations of [Ca 2ϩ ] i in VSM (25) . Many of these mechanisms have been examined in the basilar artery of rabbits (24) , dogs (31) , sheep (18) , guinea pigs (35) , and even rats (23) . However, few of these studies have examined multiple mechanisms in the same vessel and none have been done in the MCA of the rat. This latter point is potentially significant, because we (1, 33) and other researchers (19, 20) have noted that the mechanisms underlying the vasodilator response to NO appear to differ in the basilar artery and MCA of the rat. The vasodilator response to NO is completely cGMP dependent in the basilar artery of the rat (1, 29) and guinea pig (22) and is not affected by K Ca channel blockers (27) . However, ϳ50% of the response to NO in MCA of rats is cGMP independent and is secondary to blockade of the formation of 20-hydroxyeicosatetraenoic acid (20-HETE) and activation of K Ca channels (1, 33) . Furthermore, in patch-clamp studies, blockade of GC with ODQ has no effect on the ability of NO to activate K Ca channels in MCA of rats (33). These findings suggest that the vasodilator response to NO is mediated by different pathways in the MCA and basilar arteries. Given the many mechanisms that may impact on the vasodilator response to NO, and the fact that different pathways seem to underlie the vasodilator response to NO in basilar arteries and MCA of rats, it was therefore critical to determine the mechanisms that contribute to the cGMP-dependent vasodilator response to NO in the MCA of the rat. Therefore, the present study examined the following: 1) the contribution of K ϩ channels to the vasodilator responses to NO and cGMP in MCA of the rat, 2) the effects of NO and cGMP on intracellular Ca 2ϩ levels in VSM cells isolated from the MCA, and 3) the effects of NO and cGMP on the vasoconstrictor response to increases in [Ca 2ϩ ] i in MCA permeabilized with ␣-toxin and ionomycin.
METHODS

Animals.
Experiments were performed on 10-to 12-wk-old male Sprague-Dawley rats purchased from Harlan Sprague Dawley (Indianapolis, IN). The rats were housed in an Animal Care Facility at the Medical College of Wisconsin that is approved by the American Association for the Accreditation of Laboratory Animal Care. All protocols involving animals received approval by the Animal Care Committee of the Medical College of Wisconsin.
Isolated vessel studies. Rats were anesthetized with pentobarbital sodium (50 mg/kg ip), the brain was removed, and small branches of the MCA (inner diameter Ͻ100 m) were microdissected. The MCA branches were then mounted on glass micropipettes under a microscope in a chamber filled with physiological saline solution (PSS) containing (in mM) 119 NaCl, 4.7 KCl, 1.17 MgSO 4, 1.6 CaCl2, 12 NaHCO3, 1.18 NaH2PO4, 0.03 EDTA, 10 glucose, and 10 HEPES (pH 7.4). The bath was bubbled with a 95% O2-5% CO2 gas mixture and maintained at 37°C. The vessels were secured to the pipettes with 10-0 silk suture, and intraluminal pressure was maintained at 80 mmHg during the experiment. Vascular inner diameters were measured with a stereomicroscope, a charge-coupled device television camera (model KP-130AU, Hitachi), and video measurement system (model VIA-100, Boeckeler Instrument; Tucson, AZ).
Role of K ϩ channels in the vascular responses to NO and cGMP. The contribution of K ϩ channels to the vasodilator response to NO and cGMP in rat MCA was assessed by comparing the response to different concentrations of diethylaminodiazen-1-ium-1,2-dioate (DEA-NONOate; 10 Ϫ9 to 10 Ϫ5 M) and 8-bromo-cGMP (8-BrcGMP; 10 Ϫ8 to 10 Ϫ4 M) in vessels preconstricted with serotonin (5-HT; 10 Ϫ7 M) or a depolarizing concentration of KCl (80 mM). The role that activation of KCa channels plays in the vasodilator response was assessed by comparing the response to DEA-NONOate or 8-BrcGMP before and after addition of the KCa channel blocker iberiotoxin (IbTX) (10 Ϫ7 M) or a depolarizing concentration of K ϩ to the bath. The dose of IbTX used in the present study is based on previous patch-clamp data (41) and functional data (43) , indicating that this concentration of IbTX completely blocks KCa channels in VSM cells and isolated perfused arterioles.
Effects of NO and cGMP on Ca 2ϩ sensitivity in MCA. These experiments were performed using MCA mounted in a vessel myograph that were treated with ␣-toxin (10 g/ml) and ionomycin (10 Ϫ5 M) to allow for equilibration of the [Ca 2ϩ ]i and extracellular [Ca 2ϩ ]. To eliminate the possibility that changes in bath [Ca 2ϩ ] might alter vascular tone by releasing endothelial factors, the endothelium was first removed by perfusion of the vessels with PSS containing an antibody raised against the von Willebrand Factor (1:1,000 dilution) and guinea pig complement (2%) for 10 min, followed by a 20-min wash with normal PSS (12) . Endothelial function was tested in each experiment by measuring the vasodilator response to addition of ACh (10 Ϫ3 M) to the bath after preconstriction of the vessel with 5-HT (10 Ϫ7 M). After being tested for functional removal of the endothelium, the vessels were bathed with a low-Ca 2ϩ (10 Ϫ8 M) cytoplasmic substitution solution (CSS) containing (in mM) 100 potassium propionate, 4 MgCl 2, 20 piperazine-N,NЈ-bis(2-ethanesulfonic acid), 4 Na 2ATP, 10 creatinine phosphate, 0.1 mg/ml creatinine phosphokinase, and 2 EGTA, pH 7.1. Staphylococcal ␣-toxin (10 g/ml) and ionomycin (10 Ϫ5 M) were added to the bath to permeabilize the vessel to Ca 2ϩ . After 30 min, the vessels were washed with fresh low-Ca 2ϩ CSS. The degree of permeabilization was tested by comparison of the maximal vasoconstrictor response to addition of Ca 2ϩ (10 Ϫ5 M) to the bath versus the vasoconstrictor response to a depolarizing concentration of KCl (80 mM) before the vessels were treated with ionomycin and ␣-toxin.
After the vessels were permeabilized, the vasoconstrictor responses to changes in bath [Ca 2ϩ ] (10 Ϫ7 to 10 Ϫ5 M) were studied before and after the addition of DEA-NONOate (10 Ϫ6 M) or 8-BrcGMP (10 Ϫ4 M) to the bath. Other vessels were pretreated with the GC inhibitor ODQ (10 Ϫ5 M) to determine the role of cGMP in mediating the inhibitory response of the NO donor on the vasoconstrictor response to elevations in bath [Ca 2ϩ ]. Study on [Ca 2ϩ ]i in VSM cells. VSM cells were isolated from rat MCA by incubating the vessels in a low-Ca 2ϩ Tyrode solution containing (in mM) 145 NaCl, 1 MgCl2, 4 KCl, 0.05 CaCl2, 10 glucose, and 10 HEPES (pH 7.4) with 1.5 mg/ml papain (14 U/mg), and 1 mg/ml dithiothreitol for 15 min at 37°C. The vessels were then spun down and transferred to a low-Ca 2ϩ Tyrode solution composed of (in mg/ml) 0.5 elastase (90 U/ml), 1 soybean trypsin inhibitor (10,000 U/ml), and 2 collagenase (196 U/ml) for 20 min at 37°C. The supernatant was collected, and the cells were pelleted by centrifugation at 500 g for 1 min, resuspended in fresh low-Ca 2ϩ Tyrode solution, and stored at 4°C.
[Ca 2ϩ ]i were measured after loading the cells with 4 M fura 2-acetoxymethyl ester (AM) in PSS containing 0.02% pluronic acid and 1 mg/ml albumin for 45 min at room temperature. After being loaded, the cells were transferred to a 1-ml perfusion chamber on an inverted microscope and superfused with PSS at 37°C for 30 min. [Ca 2ϩ ]i was measured with the use of an imaging system (InCyt Im2, Intracellular Imaging; Cincinnati, OH) mounted on an inverted microscope (model IMT-2, Olympus Optical; Tokyo, Japan). The cells were visualized with the use of a ϫ40 ultraviolet fluorescence objective. The [Ca 2ϩ ]i were calculated based on the fluorescence intensity ratios obtained using excitation and emission wavelengths of 340/380 and 510 nm and a standard curve generated using solutions with known Drugs and chemicals. All chemicals were of analytic grade. Collagenase type II was purchased from Worthington (Freehold, NJ). DEA-NONOate and 8-BrcGMP were purchased from Calbiochem (La Jolla, CA), ODQ was obtained from Alexis (San Diego, CA), ionomycin was from Biomol (Plymouth Meeting, PA), and fura 2-AM and pluronic acid were purchased from Molecular Probes (Eugene, OR). All other chemicals used in this study were purchased from Sigma (St. Louis, MO).
Statistics. Values are presented as means Ϯ SE. The significance of differences in mean values between and within groups in the isolated vessel studies was examined using analysis of variance for repeated measurements, followed by the Duncan's multiple-range test. A paired t-test was used to examine the significance of differences in [Ca 2ϩ ]i in the studies using isolated VSM cells. P Ͻ 0.05 was considered to be significant.
RESULTS
Role of K
ϩ channels in the vasodilator response to NO and cGMP. Under control conditions, DEA-NONOate (10 Ϫ9 to 10 Ϫ5 M) dose dependently dilated MCA preconstricted with 5-HT (10 Ϫ7 M) to 79 Ϯ 4% of control (Fig. 1) . Preconstricting the vessels with a depolarizing concentration of KCl (80 mM) or addition of the selective K Ca channel blocker IbTX (10 Ϫ7 M) to the bath significantly impaired the vasodilator response to the NO donor by 50% (Fig. 1A) . In contrast, blocking K ϩ channel activity with 80 mM KCl or IbTX had little effect on the vasodilator response to 8-BrcGMP (10 Ϫ4 M) (Fig. 1B) .
Effect of NO and cGMP on the vasoconstrictor response to Ca
2ϩ in MCA permeabilized with ␣-toxin and ionomycin. Baseline diameter of the MCA used in these studies averaged 110 Ϯ 4 m. The diameter of these vessels fell to 51 Ϯ 3 m after addition of 5-HT to the ]i was due to an inability of our system to detect decreases in [Ca 2ϩ ]i, the response to addition of EDTA (10 mM) to the bath was studied at the end of each experiment.
bath and rose to 108 Ϯ 5 m after the administration of ACh. Removal of the endothelium markedly impaired the vasodilator response to ACh. Vessel diameters averaged 109 Ϯ 4, 50 Ϯ 1, and 52 Ϯ 4 m, respectively, before and after the addition of 5-HT and ACh to the bath. The control vasoconstrictor responses to elevations in bath [Ca 2ϩ ] in deendothelialized MCA subsequently treated with DEA-NONOate or 8-BrcGMP were similar. Therefore, the results from these two groups were pooled and presented together in Fig.  2 ] i increased rapidly from 88 Ϯ 11 nM to 1,580 Ϯ 211 nM after permeabilizing the cells with ionomycin (10 Ϫ5 M) and ␣-toxin (10 g/ml) in a CSS solution with a 10 Ϫ5 M free [Ca 2ϩ ] (Fig. 3B) . DEA-NONOate (10 Ϫ6 M) had no significant effect on [Ca 2ϩ ] i under these experimental conditions. Similarly ] i remained ϳ15% above control (Figs. 5 and 6 ). Addition of 8-BrcGMP to the bath during the plateau phase had no significant effect on [Ca 2ϩ ] i in VSM cells isolated from the MCA that were stimulated with 5-HT (Fig. 5) . In contrast, the NO donor DEA-NONOate reduced [Ca 2ϩ ] i by 16 Ϯ 1% (Fig. 6) . Pretreatment of the cells with IbTX potentiated the steady-state rise in [Ca 2ϩ ] i produced by 5-HT from 11 Ϯ 2 to 20 Ϯ 3% above control (Fig. 6) . Furthermore, blockade of K Ca channels also significantly reduced the fall in [Ca 2ϩ ] i from 16 Ϯ 1 to 11 Ϯ 1% after administration of DEA-NONOate to the bath (Fig. 6) .
DISCUSSION
Previous studies (5, 17, 39) have indicated that the vasodilator response to NO is mediated by cGMPdependent and -independent pathways (3, 8) . In renal arterioles (32) and MCA (17, 19, 33) of the dog and rat, activation of K Ca channels has been previously re- ported to contribute ϳ50% to the vasodilator response to NO. The increase in K Ca channel activity appears to be mediated by inhibition of the formation of 20-HETE, rather than to an elevation in cGMP levels, because preventing the NO-induced fall in 20-HETE levels by adding it to the bath abolishes the ability of a NO donor to activate K Ca channels and attenuates the vasodilator response in rat renal arterioles and MCA (32, 33) . In addition, blockade of GC with ODQ has no effect on the activation of K ϩ channels produced by NO in VSM cells isolated from rat renal arterioles and MCA (32, 33) . Nevertheless, ODQ still reduces the vasodilator response to NO by 50% in rat renal and cerebral arteries (1, 17, 33) . However, the vasodilator response to NO in basilar arteries of the rat (1, 29) and guinea pig (22) can be completely blocked by inhibition of GC. These observations suggest that the pathways underlying the vasodilator response to NO are different in the basilar artery and MCA and that cGMP contributes to the vasodilator response to NO in rat MCA via a mechanism that is independent of activation of K Ca channels.
In the present study, we first confirmed that blockade of K ϩ channels with a depolarizing concentration of KCl (80 mM) or K Ca channels with IbTX decreased the vasodilator response to NO by 50% in rat MCA under the present experimental conditions (Fig. 1) . This observation fits with previous results, indicating that activation of K ϩ channels secondary to inhibition of the formation of 20-HETE contributes ϳ50% to the vasodilator response to NO in the MCA of the rat (1, 33) . These results are also consistent with the results of other studies demonstrating that activation of K Ca channels contributes to the vasodilator response to NO in other vascular beds, including cerebral arteries studied in vitro (2, 3, 17, 21, 24, 32, 33) . However, it is important to recognize that there is not unequivocal support for a role for K Ca channels in mediating the response to NO. Indeed, studies in rat MCA (33), basilar arteries (29) , pulmonary arteries (42) , and bovine coronary arteries (15) have indicated that NO activates 4-aminopyridine-sensitive K ϩ channels. Blockade of K Ca channels with IbTX had little effect on the vasodilator response to NO and ACh in pial arteries of rabbits (34) or the basilar artery of the rat (27) studied in vivo. The vasodilator responses to sodium nitroprusside, 8-BrcGMP and ACh in these studies were attenuated by the blockade of voltage-sensitive K ϩ (K v ) channels with 4-aminopyridine. These studies indicate that in some vessels, activation of K v channels contributes to the vasodilator response to NO, whereas in others, it involves activation of K Ca channels. The reason for the differences in these results remains to be determined but may reflect species differences or differences in the types or density of K ϩ channels expressed in VSM cells in different vessels.
In contrast to what was observed after administration of the NO donor in the present study, the vasodilator response to 8-BrcGMP in MCA was not affected by blockade of K Ca channels with IbTX (10 Ϫ7 M) or by the addition of a depolarizing concentration of K ϩ to the bath. These observations are consistent with previous patch-clamp data (33), indicating that blockade of GC with ODQ does not alter the NO-induced activation of K ϩ channels in VSM cells isolated from rat MCA. Thus cGMP must contribute to the vasodilator response to NO in the MCA of the rat by some other mechanism. To evaluate this hypothesis further, we compared the effects of DEA-NONOate and 8-BrcGMP on the vasoconstrictor response to elevations in bath Ca 2ϩ in MCA permeabilized with ionomycin and ␣-toxin. We found that the NO donor DEA-NONOate (10 Ϫ6 M) produced a rightward shift of the concentration-constriction curve for Ca 2ϩ (Fig. 2) . In addition, the inhibitory effect of DEA-NONOate on Ca 2ϩ -induced vasoconstriction was not associated with a change in [Ca 2ϩ ] i in VSM cells isolated from the MCA of rats that were permeabilized with ionomycin and ␣-toxin (Fig. 3) . These findings suggest that the effect of NO to reduce the vasoconstrictor response to Ca 2ϩ in permeabilized rat MCA is not mediated by a reduction in [Ca 2ϩ ] i , but rather is due to a decrease in the contractile response to an elevation in [Ca 2ϩ ] i . The effects of NO on the vasoconstrictor response to Ca 2ϩ were completely blocked by ODQ (Fig. 2) , indicating that this effect is cGMP dependent. We also found that 8-BrcGMP mimicked the response to NO in permeabilized rat MCA and decreased the vasoconstrictor response to elevations in [Ca 2ϩ ] i (Fig. 2) . 8-BrcGMP also failed to change [Ca 2ϩ ] i in MCA VSM cells permeabilized with ionomycin and ␣-toxin (Fig. 4) . Moreover, 8-BrcGMP had no effect on [Ca 2ϩ ] i in VSM cells isolated from the MCA when studied under control condition or after the cells were stimulated with 5-HT (Fig. 5) . These results indicate that cGMP-induced attenuation of the vasoconstrictor response to elevated [Ca 2ϩ ] i in permeabilized MCA is not mediated by a decrease in [Ca 2ϩ ] i , but rather by a decrease in the contractile response to an elevation in [Ca 2ϩ ] i . In contrast to the results obtained with cGMP, we found that addition of the NO donor significantly reduced [Ca 2ϩ ] i in VSM cells stimulated with 5-HT (Fig. 6 ) and the decrease in [Ca 2ϩ ] i was attenuated, but not eliminated, by blockade of K Ca channels with IbTX (Fig. 6 ). These findings are consistent with the view that NO-induced activation of K Ca channels contributes to the fall in [Ca 2ϩ ] i by hyperpolarizing the cell membrane and reducing Ca 2ϩ influx through voltage-gated Ca 2ϩ channels (23) . They also indicate that other mechanisms contribute to the decrease in [Ca 2ϩ ] i produced by NO in these vessels, because blockade of K Ca channels did not completely block the NO-induced fall in [Ca 2ϩ ] i . These mechanisms include activation of other type of K ϩ channels (29, 33, 34) and/or stimulation of Ca 2ϩ reuptake into intracellular stores as reported by Twort and van Breemen (37) .
The mechanism by which cGMP decreases the vasoconstrictor response to elevations in [Ca 2ϩ ] i in the rat MCA remains to be determined. Contraction of VSM is dependent on the phosphorylation and dephosphorylation of the myosin light chain protein (30) . Phosphorylation of the myosin light chain is mediated by Ca 2ϩ -calmodulin activated myosin light-chain kinase, and dephosphorylation depends on myosin light chain phosphatase. Thus a decrease of the activity of Ca 2ϩ -calmodulin activated myosin light-chain kinase and/or an increase in the activity of myosin light chain phosphatase could contribute to the decrease in the contractile response to an elevation of [Ca 2ϩ ] i . Indeed, several investigators (13, 25, 38, 40) have reported that cGMP activates protein kinases that phosphorylate and modify the activity of both of these enzymes. Thus it is likely that both mechanisms contribute to the cGMPinduced fall in the vasoconstrictor response to elevations in [Ca 2ϩ ] i in rat MCA. In summary, the present results indicate that the vasodilator response to NO in the MCA of the rat is mediated by activation of K Ca channels (cGMP independent) and cGMP-dependent pathways and the cGMP-dependent pathway is mediated by an effect of cGMP to decrease the contractile response to elevations in [Ca 2ϩ ] i , rather than by activation of K ϩ channels or a fall in [Ca 2ϩ ] i .
